fied CRP significantly induced protein release and mRNA expression of IL-6 and TSP-1 in a dose-and time-dependent manner. TGF-␤ 1 protein was overexpressed in HK-2 cells induced by CRP, which cannot be inhibited by IL-6 or TSP-1 antibodies. CRP triggered phosphorylation of p38MAPK and activation of NF-B-mediated signal transduction. SB203580 (5 M ) and PDTC (50 M ) efficiently suppressed those effects of CRP in HK-2 cells. Conclusions: CRP induces IL-6 and TSP-1 protein release and mRNA expression from HK-2 cells via activation of the p38MAPK and NF-B signaling pathways and TGF-␤ 1 was highly expressed in HK-2 cells, suggesting that CRP plays an important role in the propagation and prolongation of inflammation in renal fibrosis.
fied CRP significantly induced protein release and mRNA expression of IL-6 and TSP-1 in a dose-and time-dependent manner. TGF-␤ 1 protein was overexpressed in HK-2 cells induced by CRP, which cannot be inhibited by IL-6 or TSP-1 antibodies. CRP triggered phosphorylation of p38MAPK and activation of NF-B-mediated signal transduction. SB203580 (5 M ) and PDTC (50 M ) efficiently suppressed those effects of CRP in HK-2 cells. Conclusions: CRP induces IL-6 and TSP-1 protein release and mRNA expression from HK-2 cells via acphysiologic process that underlies diabetes and that these cytokines contribute to a considerable degree to renal dysfunction [2, 3] . CRP has been proposed to be an independent risk factor for atherosclerosis [4] [5] [6] [7] . Several studies have shown that CRP has direct proinflammatory effects on vascular cells, such as activation of the classical complement pathway, induction of adhesion molecules, and inhibition of nitric oxide production [8] [9] [10] [11] . However, the molecular effect of CRP on human kidney tubular epithelial cells (HK-2 cells) during the inflammatory processes remains to be explored.
Tubular epithelial cells are now believed to play a major role in the progression and maintenance of tubulointerstitial fibrosis. Tubular epithelial cells can undergo a phenotypic change towards a myofibroblast-like phenotype, which indicates that transdifferentiation of tubular epithelial cells plays a role in progressive renal fibrosis in human glomerulonephritis [12] .
Thrombospondin-1 (TSP-1) and interleukin-6 (IL-6) play a critical role in the development of renal tubulointerstitial fibrosis [13, 14] . The present study was undertaken to investigate the effect of CRP on the secretion of IL-6 and TSP-1 using HK-2 cells. The underlying intracellular signal transduction pathways were also investigated.
Materials and Methods
Purification of CRP CRP (human) was obtained from American Sigma (St. Louis, Mo., USA) and purified (to remove possible biological contaminants, such as sodium azide and LPS) as described previously [15] . The content of LPS in the purified CRP solutions (5, 10, 20 and 40 g/ml) was found to be ! 5 pg/ml, as determined using Limulus endotoxin assays. The purity of CRP preparations was determined using 12.5% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). A 25-kDa single band corresponding to CRP was observed after staining gels with sensitive silver staining. In brief, CRP was filtered with Amicon-Ultra 4 (10,000 molecular weight cut off; Millipore Corporation, Bedford, Mass., USA) at 4 ° C and then washed twice with 20 ml of 0.9% NaCl solution in an intravenous solution (Otsuka, Tokushima, Japan). After CRP had been washed, its concentrations were measured using a commercial enzyme-linked immunosorbent assay (ELISA) kit specific for human CRP (Alpha Diagnostic International, Tex., USA). In some experiments, the purified CRP was immunoprecipitated with anti-CRP antibody (Dako Cytomation, Denmark) or nonimmune control IgG (Dako Cytomation), followed by a 16-hour incubation of protein G agarose (Santa Cruz Biotechnology, Inc.). The immunoprecipitated proteins were separated by centrifugation, and supernatants were collected for cell stimulation. Experiments were performed with the purified CRP, unless stated otherwise.
Cell Culture HK-2 cells were obtained from the American Type Culture Collection and maintained in Opti-MEM-I medium (Gibco BRL) supplemented with 10% fetal bovine serum and 2 m M glutamine. HK-2 cells were used at passage 3 or 4 in all the experiments.
Stimulation of HK-2 Cells with CRP
Before stimulation with the purified CRP or PBS, HK-2 cells (2 ! 10 6 cells/6-cm dish) were starved for 24 h with serum-free Opti-MEM-I medium. HK-2 cells were treated with various concentrations (0, 5, 10, 20 and 40 g/ml) of the purified CRP for 24 h. HK-2 cells were pretreated with SB203580 (5 M ) or pyrrolidine dithiocarbamate (PDTC) (50 M ) for 60 min separately and then stimulated with CRP (20 g/ml). Following treatment, IL-6 and TSP-1 levels in the culture media were analyzed via RT-PCR and ELISA.
ELISA Analysis for IL-6 and TSP-1
The levels of IL-6 and TSP-1 in cultured supernatants were determined using a commercial ELISA kit specific for human IL-6 (R&D Systems, Minneapolis, Minn., USA) and TSP-1 (ADL systems) according to the manufacturers' recommendations. These assays employ the quantitative sandwich enzyme immunoassay techniques using a rat monoclonal antibody against murine IL-6 or TSP-1 polyclonal secondary antibody conjugated with horseradish peroxidase. All experiments were performed in triplicate.
RT-PCR for IL-6 mRNA and TSP-1 mRNA Expression RNA was isolated and purified using an RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. The primers used were: IL-6 -sense: 5 -GGAGACGCCTTGAAGTAACTGC-3 , antisense: 5 -GAGTTTCCTCTGACTCCATCGCAG-3 . TSP-1 -sense 5 -AAAGCGTCTTCACCAGAGACC-3 , antisense: 5 -GCAGATGGTAACTGAGTTCTGACA-3 .
PCR assays for IL-6 were performed with a thermal cycler protocol of 50 ° C for 2 min before the first cycle, then 95 ° C for 15 s, and 60 ° C for 1 min, with this cycle repeated 45 times. PCR for TSP-1 was carried out with a thermal cycler protocol of 94 ° C for 3 min before the first cycle, then 94 ° C for 60 s and 55 ° C for 60 s, with this cycle repeated 35 times. For PCR amplification assays, GAPDH was used as a control [16] .
Western Blot Analysis of TSP-1, IL-6, Transforming Growth
Factor-␤ 1 (TGF-␤ 1 ) and Phosphorylated-p38MAPK HK-2 cells (2 ! 10 6 cells/ml) cultured in 6-cm dishes for 24 h were washed with Opti-MEM-I medium and then treated with different doses of CRP (5, 10, 20 and 40 g/ml) for 20 h. The collected culture cells were then analyzed for TSP-1, IL-6 and p38MAPK levels via Western blot analysis.
Preparation of supernatant samples and Western blot analyses were performed as described previously [17, 18] . Briefly, cell lysates (50 g) obtained from CRP-treated HK-2 cells samples (40 l) extracted from heparin beads were subjected to 12% SDS-PAGE, and the separated proteins were then transferred onto a nitrocellulose membrane (Amersham Biosciences). The membrane was blocked with 5% nonfat dry milk in Tris-buffered saline (pH 7.4) containing 0.02% Tween 20 (TBST) for 1 h at room temperature and then incubated with an anti-TSP-1 antibody (2 g/ml), anti-IL-6 antibody (2 g/ml), anti-TGF-␤ 1 antibody (2 g/ml) or an anti-p38MAPK antibody (2 g/ml) separately in TBST containing 1% nonfat dry milk for 3 h at room temperature. The membrane was then washed and incubated with a horseradish-peroxidase-conjugated anti-rabbit IgG polyclonal antibody (Santa Cruz) diluted 1: 3,000 in TBST containing 2.5% nonfat dry milk for 1 h at room temperature. The membrane was then washed a second time, and immunoreactive bands were visualized using an ECL detection system.
Electrophoretic Mobility Shift Assay (EMSA) for Nuclear Factor-Kappa-B (NF-B) Activation
An EMSA test kit was obtained from Promega. Nuclear extracts from HK-2 cells were prepared according to the method of Beg et al. [19] . Binding reactions were performed in a 20-l volume containing 4 g of nuclear protein extracts, 10 m M Tris-Cl (pH 7.5), 50 m M NaCl, 1 m M EDTA, 0.1 m M dithiothreitol, 10% glycerol, 2 g of poly(dI-dC) (nonspecific competitor), and 40,000 cpm of 32 P-labeled specific oligonucleotide probe. Doublestranded oligonucleotides containing the consensus sequence of the binding site for transcription factor NF-B (5 -AGTTGAGGGGA-CTTTCCCAGG-3 ) were purchased from Promega and labeled with [ ␥ -32 P]-ATP (Amersham Pharmacia) using T4 polynucleotide kinase. Binding reactions were performed at 37 ° C for 30 min in 30 l of reaction buffer containing 10 m M Tris-HCl (pH 7.5), 100 m M NaCl, 1 m M EDTA, 4% glycerol, 1 g of poly(dI-dC), and 1 m M DTT. DNA-protein complexes were separated from the unbound DNA probe on native 5% polyacrylamide gels at 100 V in 0.5 ! TBE buffer. The gels were then dried and exposed to X-ray film at -70 ° C for 24 h. The intensity of the bands corresponding to specific NF-B-DNA binding was determined via laser scanning (Typhoon 9200 type, Sweden) with gel Imagequant software.
Statistical Analysis
All data are presented as means 8 SE. An unpaired Student's t test was used for comparison between the treated and control groups. Additionally, ANOVA with posthoc analysis was used to compare multiple groups (SPSS 11.0). p ! 0.05 was considered statistically significant.
Results

Dose-and Time-Dependent Effect of CRP on TSP-1 and IL-6 Release in HK-2 Cells
The level of TSP-1 in supernatants of HK-2 cells was 122 8 38 pg/ml in the absence of CRP, but increased in a dose-dependent manner as cells were stimulated by CRP (at a concentration of 5 g/ml, the level of TSP-1 was 273 8 47 vs. 122 8 38 pg/ml, p ! 0.05) ( fig. 1 a) . IL-6 was rarely detected in the cultured medium in the absence of CRP (12 8 4 pg/ml); at a concentration of 5 g/ml, however, CRP triggered a marked increase in IL-6 levels (152 8 13 vs. 12 8 4 pg/ml, p ! 0.001), which was significantly upregulated at concentrations of CRP 6 20 g/ml (806 8 72 pg/ml) ( fig. 1 b) .
We evaluated the time-course effects of CRP stimulation on IL-6 and TSP-1 release. IL-6 and TSP-1 were detected in the culture medium after 6 h and continued to increase up to 24 h in response to 20 g/ml CRP treatment ( fig. 1 c) .
We also evaluated the role of the activation of p38MAPK in cytokines release by examining whether a specific inhibitor of p38MAPK (SB203580) could suppress the CRP-induced inflammatory response by HK-2 cells. Cells were treated with SB203580 (5 M ) for 60 min prior to CRP stimulation and were then left in culture until they were harvested 24 h poststimulation. We found that SB203580 significantly suppressed CRP-induced IL-6 and TSP-1 release (p ! 0.05) ( fig. 1 a, b) .
We also evaluated the role of the activation of NF-B in cytokine release by examining whether a specific inhibitor of NF-B (PDTC) could suppress the CRP-induced inflammatory response by HK-2 cells. Cells were treated with PDTC (50 M ) for 60 min prior to CRP stimulation and were then left in culture until they were harvested 24 h poststimulation. We found that NF-B significantly suppressed CRP-induced IL-6 and TSP-1 release (p ! 0.05) ( fig. 1 a, b) .
CRP Significantly Induced TGF-␤ 1 Directly in HK-2 Cells
TGF-␤ 1 expression was detected through ELISA. The levels of TGF-␤ 1 among the three groups (group 1, CRP stimulation alone; group 2, CRP with IL-6 antibody; group 3, CRP with TSP-1 antibody) were higher compared with the control group (56 8 12 pg/ml) ( table 1 ). Although the cells were preincubated with IL-6 or TSP-1 antibody, the levels of TGF-␤ 1 were still as high as in the CRP group (378 8 71, 369 8 56, vs. 398 8 65 pg/ml, respectively, p 1 0.05), there are no significant differences among those three groups, which indicated that the role of CRP on HK-2 cells is direct and not through the IL-6 or TSP-1 pathways ( table 1 ) .
CRP Significantly Induced IL-6 and TSP-1 mRNA Expression in HK-2 Cells
At a concentration of as low as 5 g/ml, CRP induced the expression of IL-6 and TSP-1 mRNA in HK-2 cells. The increase of mRNA expression was significant in comparison to the negative control group (p ! 0.05) ( fig. 2 ) and proved to be dose-dependent. This effect was inhibited by preincubation of the cells with the p38MAPK-specific inhibitor SB203580 (5 M) for 60 min prior to CRP stimulation, which indicates that p38 was involved in the inflammatory response induced by CRP ( fig. 2 ) .
CRP Triggered the Activation of NF-B in HK-2 Cells
We examined whether CRP stimulates the activation of NF-B in HK-2 cells via EMSA. CRP stimulation caused a marked activation of NF-B in a dose-dependent manner in HK-2 cells ( fig. 3 a) . When SB203580 was added, the activation of NF-B decreased significantly compared to the CRP (20 g/ml) group (p ! 0.05). The similar effect of CRP on activation was inhibited by PDTC ( fig. 3 b) . These results suggest that the CRP-induced cytokine release may be induced by the activation of NF-B.
Involvement of p38MAPK in CRP-Induced TSP-1 and IL-6 Release
Recent studies have demonstrated that CRP activates MAPKs through the Fc ␥ receptor (Fc␥ R) [20] . We examined whether CRP stimulates the activation of MAPKs in HK-2 cells via Western blot analysis. ␤ -Actin was used as a loading control in these assays. CRP stimulation caused a marked activation of p38MAPK in HK-2 cells in a dosedependent manner ( fig. 4 a) . SB203580 inhibited the activation of p38MAPK compared to the CRP (20 g/ml) group (p ! 0.05). These results indicate the possibility that CRP-induced cytokine release may depend, at least in part, on the phosphorylation of p38MAPK ( fig. 4 b) .
Effect of CRP on the TSP-1, IL-6 and TGF-␤ 1 Expression of HK-2 Cells Determined via Western Blot Analysis
Cells were incubated with PBS -group CRP (5, 10, 20 and 40 g/ml). Also, the cells were preincubated by SB203580 (5 M ) for 2 h or PDTC (50 M ) and then stimulated with CRP (20 g/ml). Western blot analysis was conducted to confirm the effect of CRP on HK-2 cells.
At a concentration of 5 g/ml, CRP induced the expression of IL-6, TSP-1 and TGF-␤ 1 protein in HK-2 cells. The increase of these protein expressions was significant separately in comparison to the negative control group (p ! 0.05) ( fig. 5 ) and proved to be dose-dependent. These effects were inhibited by preincubation of the cells with the p38MAPK-specific inhibitor SB203580 (5 M) or PDTC (50 M) for 60 min prior to CRP stimulation, which indicates that p38 phosphorylation and NF-B activation were involved in the inflammatory response induced by CRP ( fig. 5 ).
Discussion
Kidney disease is characterized by extensive tubulointerstitial fibrosis and is one of the most serious complications associated with diabetes. Tubulointerstitial fibrosis is regarded as the final common pathway in kidney disease progression as the extent and severity of tubulointerstitial fibrosis correlates most closely with declining renal function. To provide evidence for potential links among CRP, TSP-1, IL-6 and tubulointerstitial fibrosis in the current study, we used a human tubular cell line (HK-2) to examine the cellular responses to CRP. Previous studies have reported that serum or urinary levels of inflammatory parameters, including C-reactive protein and IL-6 [21] are elevated in patients with type 2 diabetic nephropathy [22] . TSP-1 is a multifunctional glycoprotein synthesized by many cells [23] and is involved in angiogenesis and inflammation. IL-6 plays a critical role in chronic inflammatory diseases [24] .
In this study, we have demonstrated that purified CRP (sodium azide-and LPS-free) induced the active release of TSP-1 and IL-6 by HK-2 cells in a time-and dose-dependent manner. Purified CRP (20 g/ml) induced a significant release of TSP-1 and IL-6 by HK-2 cells ( fig. 1 a,  b ) compared to the negative control group. CRP at concentrations of 1 5 pg/ml has been shown to stimulate HK-2 cells to release the inflammatory cytokine, implying that CRP can trigger the inflammatory response of HK-2 cells. The concentrations of CRP (5-40 g/ml) used in the present study are equivalent to those observed in patients suffering from diabetic nephropathy, obesity and cardiovascular diseases [25, 26] .
TSP-1 is a major endogenous activator for TGF-␤ 1 , which plays a critical role in the development of renal tubulointerstitial fibrosis. In the study, the levels of TGF-␤ 1 were also detected in HK-2 cells which were preincubated with IL-6 or TSP-1 antibody. The levels of TGF-␤ 1 induced by CRP (20 g/ml) were significantly increased compared with the control group ( table 1 ), but adding the IL-6 antibody or TSP-1 antibody cannot block the effect of CRP (IL-6 antibody: 378 8 71 pg/ml, TSP-1 antibody: 369 8 56 pg/ml, vs. CRP alone: 398 8 65 pg/ml, p 1 0.05). The results indicated that the role of CRP on HK-2 cells is direct and not through the IL-6 or TSP-1 pathways. The findings of the present study -that CRP induced HK-2 cells to release TSP-1 and IL-6 -indicate an important pathophysiologic role for CRP in the inflam- This induction of TSP-1 and IL-6 release was mediated by p38MAPK. The effect of CRP was inhibited by the p38MAPK inhibitor SB203580 through ELISA and Western blot analysis in the study, again confirming this direct role of CRP on HK-2 cells. The p38MAPK signaling pathway plays an important role in promoting inflammatory diseases [27] [28] [29] . Activation of p38MAPK induces the production of key inflammatory mediators like TNF-␣ and IL-6 [30] [31] [32] , suggesting that p38MAPK is an obvious therapeutic target for chronic inflammatory diseases.
In the current study, we observed that CRP triggered the activation of NF-B in a dose-dependent manner. PDTC (a metal chelator and antioxidant) can inhibit the activation of NF-B specifically by suppressing the release of the inhibitory subunit IB from the latent cytoplasmic form of NF-B [33] . NF-B played a crucial role in CRP-induced cytokine release, suggesting the involvement of NF-B in the CRP-induced inflammatory response of HK-2 cells. The activation of NF-B transcrip- tional programs that control the expression of the genes activated during inflammation in human diabetic nephropathy has recently been described [34] . IL-6 acts on its receptor, RAGE, and activates NF-B signaling to induce the expression of proinflammatory cytokines like TNF-␣ . TGF-␤ , has been shown to stimulate vascular endothelial cells, thereby upregulating adhesion molecules like ICAM-1, and inducing granulocyte colony-stimulating factor expression and IL-8 release [35] [36] [37] . CRP induces the expression of IL-6 in tubular cells, suggesting that CRP promotes renal tubular epithelial cell activation and dysfunction. At the same time, it is a positive feedback cycle where IL-6 can also be transcribed by NF-B induced by CRP. CRP may thus enhance the tubulointerstitium by inducing the inflammatory component of diabetic nephropathy [38, 39] .
It has been previously demonstrated that Fc ␥ RIIB underlies the actions of CRP on the vascular endothelium [40] . In kidney tubular cells, by contrast, the molecular and functional characteristics of Fc ␥ R have remained unclear. Further studies are needed in order to identify the basis of the CRP-mediated processes in tubular cells. In particular, Baer et al. [41] have previously reported MAPK activation and RANTES induction by CRP in human renal distal tubular cells, and NF-B activation by CRP in human mesangial cells has been reported by Chang et al. [42] . More recently, p38 activation and cytokine expression by CRP were demonstrated in vascular smooth muscle cells. Our study indicated that CRP induces IL-6 expression, which then activates NF-B, thus enhancing the CRP actions on tubular cells, which is in contrast to previous studies [43] describing that IL-6 is not induced by CRP. Moreover, it has been demonstrated that although IL-6 gene expression requires NF-B activation, IL-6 itself is a weak NF-B inducer, and preferentially acts through the JAK/STAT pathway in different cell types. Our findings suggest that CRP plays a potentially important role in the induction of inflammatory processes, including tubulointerstitial fibrosis, by inducing the release of the key inflammatory mediators IL-6 and TSP-1, and thus presents a potential target for the treatment of tubulointerstitial fibrosis in cases of diabetic nephropathy.
Conclusion
The interaction between the proinflammatory cytokines CRP, TSP-1 and IL-6 in renal tubular epithelial cells was previously unclear. Here, we show that CRP induces HK-2 cells to release cytokine via activation of the p38MAPK and NF-B signaling pathways, suggesting that CRP plays an important role in the propagation and prolongation of inflammation of tubular epithelial cells in cases of tubulointerstitial fibrosis and diabetic nephropathy.
